Alibaba
BABA
Apple
AAPL
Netflix
NFLX
Tesla
TSLA
Microsoft
MSFT
US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 21.5800
- +0.7500+3.60%
Close Mar 27 16:00 ET
- 21.5800
- 0.00000.00%
Post 16:36 ET
236.38MMarket Cap-0.81P/E (TTM)
21.9250High19.8300Low67.45KVolume20.5500Open20.8300Pre Close1.44MTurnover1.48%Turnover RatioLossP/E (Static)10.95MShares28.420052wk High1.45P/B98.55MFloat Cap10.000052wk Low--Dividend TTM4.57MShs Float382.6000Historical High--Div YieldTTM10.06%Amplitude8.0000Historical Low21.4190Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Cidara Therapeutics Stock Forum
Revolutionary Universal Flu Drug Shows Promise Against All Strains, Including Bird Flu
Can Cidara's $196M War Chest and 5,000-Patient Trial Transform Flu Prevention?
RBC Capital Initiates Coverage On Cidara Therapeutics with Outperform Rating, Announces Price Target of $34
Cidara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.2%),TCG Crossover Fund II, L.P.(9.2%), etc.
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not all bad news crash the pri...
Cidara Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Cash available will sustain the operations for 24 months (exclude 105mil private placement). Upcoming catalyst September 2025.
No comment yet